Esketamine nasal spray vs quetiapine extended-release: examining work productivity loss and related costs in patients with treatment-resistant depression / Kristin Clemens en The Journal of Clinical Psychiatry, Año 2025 - Vol. 86 - No.1 (Marzo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2025 - Vol. 86 - No.1 (Marzo) . - pp. 60-67 Título : Esketamine nasal spray vs quetiapine extended-release: examining work productivity loss and related costs in patients with treatment-resistant depression Tipo de documento: texto impreso Autores: Kristin Clemens, Autor ; Amanda Teeple, Autor ; Maryia Zhdanava, Autor Fecha de publicación: 2025 Artículo en la página: pp. 60-67 Idioma : Inglés (eng) Idioma original : Inglés (eng) Etiquetas: Agentes antipsicóticos, Trastorno depresivo resistente al tratamiento, Terapia farmacológica combinada, Ketamina, Aerosoles nasales, Fumarato de quetiapina. Resumen: This post hoc analysis of the ESCAPE-TRD trial compared work productivity loss (WPL) and related costs among patients with treatment-resistant depression (TRD) receiving esketamine nasal spray or quetiapine extended release in combination with an oral antidepressant. Link: ./index.php?lvl=notice_display&id=31617 [artículo] Esketamine nasal spray vs quetiapine extended-release: examining work productivity loss and related costs in patients with treatment-resistant depression [texto impreso] / Kristin Clemens, Autor ; Amanda Teeple, Autor ; Maryia Zhdanava, Autor . - 2025 . - pp. 60-67. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2025 - Vol. 86 - No.1 (Marzo) . - pp. 60-67 Etiquetas: Agentes antipsicóticos, Trastorno depresivo resistente al tratamiento, Terapia farmacológica combinada, Ketamina, Aerosoles nasales, Fumarato de quetiapina. Resumen: This post hoc analysis of the ESCAPE-TRD trial compared work productivity loss (WPL) and related costs among patients with treatment-resistant depression (TRD) receiving esketamine nasal spray or quetiapine extended release in combination with an oral antidepressant. Link: ./index.php?lvl=notice_display&id=31617

---

1 (1 - 1 / 1)